Categories: All postsCannabis

Village Farms is “impressive”, GMP Securities says

Quarterly numbers from Village Farms International (Village Farms International Stock Quote, Chart TSX:VFF) show an impressive ramp-up in the company’s cannabis production, which along with industry-leading margins and a recent pullback in VFF’s share price makes for a compelling entry point for investors, says Martin Landry, analyst for GMP Securities.

On Friday, the analyst reaffirmed his “Buy” recommendation and $22.50 target price.

Produce and cannabis grower Village Farms released its first quarter fiscal 2019 financials on Thursday, coming in with $14.4 million in revenue at its cannabis joint venture Pure SunFarms and EBITDA of $8.6 million, both ahead of Landry’s estimates of a $10.5 million top line and $4.8 million in EBITDA. (All figures in Canadian dollars unless noted otherwise.)

In a note to clients, Landry points to PSF’s EBITDA margin of 60 per cent, the highest among cannabis companies that GMP covers and similar to the gross margins of other licensed producers who have been in the industry for much longer than PSF, Landry says.

“The ramp up at Pure Sunfarms (PSF) has been impressive, having achieved sales of $14m in its second quarter of revenue generation. Despite being in production for such a short period of time, Pure Sunfarms is already generating higher revenue than some LPs,” says Landry.

The analyst says PSF is on track to meet its previous guidance for its 2019 hemp acreage in the US and to begin selling CBD oil wholesale in early 2020, followed by white label and branded products. He notes that Village Farms is exploring additional hemp opportunities in Mexico and Latin America. All told, Landry says that PSF is on track to be producing at an annualized run-rate of 75 tonnes by mid-2019.

Landry thinks VFF will generate 2019 EBITDA of US$23.1 million and 2020 EBITDA of US$49.0 million. His $22.50 target represents a projected return of 52.4 per cent at the time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: vff
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

16 hours ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

16 hours ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

17 hours ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

3 days ago

Is SNAP a buy right now?

He feels the company made forward progress in its recent quarterly results, but Roth MKM analyst Rohit Kulkarni wants to… [Read More]

3 days ago

Bombardier wins price target raise at Desjardins

Following the company's first quarter results, Desjardins analyst Benoit Poirier has raised his price target on Bombardier (Bombardier Stock Quote,… [Read More]

4 days ago